|
VIRX Viracta Therapeutics Inc 1061027 |
| Balance Sheet |
|
Current Assets
|
21,803,000 |
|
Assets
|
21,958,000 |
|
Current Liabilities
|
28,575,000 |
|
Liabilities
|
28,575,000 |
|
Equity
|
-6,617,000 |
|
Shares Out
|
39,417,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-24,769,000 |
|
Investing Cash Flow
|
34,055,000 |
| Market Analysis |
Market Cap
|
9,102,213 |
|
Price
|
0.02 |
|
BVPS
|
0.18 |
|
PB
|
0.11 |
|
EPS
|
-1.16 |
|
PS
|
11.33 |
|
FCF
|
9,286,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VIRX documents filed with the SEC.
VIRX Filings
Clear
